Distribution of P2Y receptor subtypes on haematopoietic cells

British Journal of Pharmacology
J JinS P Kunapuli

Abstract

1. RT-PCR-southern hybridization analyses with radiolabelled P2Y receptor cDNAs as probes indicated that the peripheral blood leukocytes and the human umbilical vein endothelial cells express P2Y1, P2Y2, P2Y4 and P2Y6 receptors. 2. Of the haematopoietic cell lines tested, promonocytic U937 cells express P2Y2 and P2Y6, but not P2Y1 or P2Y4; promyelocytic HL-60 cells express the P2Y1, P2Y2 and P2Y6 receptors but not the P2Y4 receptor; K562 cells express P2Y1 but not P2Y2, P2Y4 or P2Y6; and Dami cells express P2Y1, P2Y2, P2Y4 and P2Y6 receptors. 3. Of the peripheral blood leukocytes tested, polymorphonuclear cells express P2Y4 and P2Y6 but not P2Y1 or P2Y2 receptors; monocytes express P2Y1, P2Y2, P2Y4 and P2Y6 receptors and lymphocytes express P2Y1, P2Y2, P2Y4 and P2Y6 receptors. 4. These results suggest a physiological role for different P2Y receptor subtypes in the extracellular nucleotide-mediated stimulation of monocytes, neutrophils, lymphocytes and endothelial cells.

References

Jan 15, 1986·The Biochemical Journal·J L Gordon
Oct 1, 1986·The Journal of Clinical Investigation·D C AltieriA M Capitanio
Nov 3, 1995·The Journal of Biological Chemistry·K ChangY Takuwa
Apr 1, 1995·Trends in Pharmacological Sciences·M R BoarderG F Wilkinson
Jun 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·K D LustigD Julius
Jan 1, 1994·Pharmacology & Therapeutics·M P Abbracchio, G Burnstock
Aug 1, 1994·Trends in Pharmacological Sciences·M R BoarderG A Weisman
Dec 20, 1994·Proceedings of the National Academy of Sciences of the United States of America·C E ParrJ T Turner
Apr 1, 1994·Trends in Pharmacological Sciences·S M Hourani, D A Hall
Apr 12, 1994·Proceedings of the National Academy of Sciences of the United States of America·C E ParrJ T Turner
Dec 29, 1995·The Journal of Biological Chemistry·T NguyenB F O'Dowd
Dec 29, 1995·The Journal of Biological Chemistry·D CommuniJ M Boeynaems
Jan 26, 1996·Biochemical and Biophysical Research Communications·K AyyanathanS P Kunapuli
Feb 6, 1996·Biochemical and Biophysical Research Communications·T E WebbE A Barnard
May 15, 1996·Biochemical and Biophysical Research Communications·D CommuniJ M Boeynaems
Aug 2, 1996·The Journal of Biological Chemistry·G K AkbarS P Kunapuli
May 1, 1996·Journal of Receptor and Signal Transduction Research·G K AkbarS P Kunapuli
Aug 1, 1997·Biochemical Pharmacology·K ZurbonsenC Chevillard
Jul 1, 1997·Somatic Cell and Molecular Genetics·L V PidlaoanS P Kunapuli
Jan 1, 1996·Platelets·C GachetJ P Cazenave

❮ Previous
Next ❯

Citations

Dec 7, 2006·Archives of Pharmacal Research·Mi-Jung YoonDong-Ku Kim
Apr 12, 2008·Purinergic Signalling·Daniel Myrtek, Marco Idzko
Apr 12, 2008·Purinergic Signalling·Christopher A Gabel
Apr 6, 2001·European Journal of Pharmacology·N Suarez-HuertaB Robaye
Aug 31, 2001·European Journal of Pharmacology·A D ConigraveJ S Wiley
Aug 11, 2000·Immunopharmacology·V R DasariS P Kunapuli
Jun 28, 2000·Journal of the Autonomic Nervous System·M S FaguraP Leff
Feb 13, 2001·Journal of Dermatological Science·W K LeeH O Kim
Oct 24, 1998·British Journal of Pharmacology·A R ConantA W Simpson
Feb 28, 2002·British Journal of Pharmacology·Francesco Di Virgilio, Anna Solini
Aug 18, 2000·Immunology and Cell Biology·L van der WeydenM B Morris
Mar 30, 2010·Acta Physiologica·G BurnstockA Verkhratsky
Jun 8, 2012·American Journal of Physiology. Cell Physiology·Juliana I SesmaEduardo R Lazarowski
May 2, 2014·Experimental Cell Research·Anfei HuangJinping Zhang
Jan 12, 2013·American Journal of Physiology. Gastrointestinal and Liver Physiology·Angela K MossRichard A Hodin
Jun 16, 2007·International Immunopharmacology·C EvaldssonS Uppugunduri
Oct 3, 2003·British Journal of Pharmacology·Reza D BeigiGeorge R Dubyak
Nov 3, 2011·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Gordon J ZwartzLarry A Sklar
Jul 6, 2006·European Journal of Pharmacology·Michelle Scrivens, John M Dickenson
Nov 11, 2005·Biochemical Pharmacology·Liaman MamedovaKenneth A Jacobson
Jul 1, 2004·The Journal of Biological Chemistry·Gordon J ZwartzLarry A Sklar
Mar 28, 2003·Journal of Leukocyte Biology·Katrin SakHele Everaus

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.